Women less likely to receive evidence-based heart failure treatment

The Pharmaceutical Journal Group

首页> 外文期刊>The pharmaceutical journal >Women less likely to receive evidence-based heart failure treatment

【24h】

Women less likely to receive evidence-based heart failure treatment

机译：女性不太可能接受循证性心力衰竭治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Women with heart failure are less likely to receive guideline-recommended medicines, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) or beta-blockers, than men, according to a study published online in the European Journal of Heart Failure on 21 January 2009.

机译：根据《欧洲杂志》在线发表的一项研究，与男性相比，患有心力衰竭的女性不太可能接受指南推荐的药物，例如血管紧张素转化酶（ACE）抑制剂，血管紧张素受体阻滞剂（ARB）或β受体阻滞剂。 2009年1月21日发生心力衰竭。

著录项

来源
《The pharmaceutical journal》 |2009年第7537期|共1页
作者
The Pharmaceutical Journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Women less likely to receive evidence-based heart failure treatment [J] . The Pharmaceutical Journal Group The pharmaceutical journal . 2009,第7537期

机译：女性不太可能接受循证性心力衰竭治疗
2. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the assessment of treatment with lisinopril [J] . Majumdar SR, McAlister FA, Cree M, Clinical therapeutics . 2004,第5期

机译：以证据为基础的治疗方法是否已为已经接受血管紧张素转换酶抑制剂的充血性心力衰竭患者提供了增量收益？赖诺普利治疗评估对一年结局的辅助分析
3. Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men [J] . Tyler P. Rasmussen, Noah N. Williford, Christopher DeZorzi, Cardiology research and practice . 2019,第1期

机译：与男性相比，女性为慢性失代偿的收缩期心力衰竭接受慢性失代偿的收缩性心力衰竭而接受较少的呋塞米
4. Heart Failure Patients are not Receiving Evidence-Based Lifesaving Drug Therapy: Lessons from the Heart Failure Adherence and Retention Trial (HART) [C] . Calvin Jr. J.E., Powell L.H., Richardson D., International Congress on Coronary Artery Disease . 2009

机译：心力衰竭患者没有接受基于证据的救生药物治疗：来自心力衰竭依从性和保留试验的教训（HART）
5. Existential Factors Influencing End-of-Life Treatment Decision Making: The Role of Death Anxiety And Meaning In Life in Choosing to Receive Destination Therapy Left Ventricular Assist Device in Advanced Heart Failure Patients [D] . Clement, Lacey Renee. 2018

机译：影响生命结束治疗决策的存在因素：在先进心力衰竭患者中选择接受目的地疗法左心室辅助装置的生活中死亡焦虑和意义的作用
6. Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men [O] . Tyler P. Rasmussen, Noah N. Williford, Christopher DeZorzi, 2019

机译：因慢性失代偿性收缩期心力衰竭住院的女性比男性少接受速尿
7. ELDERLY PATIENTS ARE LESS LIKELY TO RECEIVE EVIDENCE-BASED MEDICATIONS INDICATED FOR SYSTOLIC HEART FAILURE: RESULTS FROM THE STUDY OF ANEMIA IN A HEART FAILURE POPULATION (STAMINA-HFP) REGISTRY [O] . Pina Ileana L., Boxer Rebecca S., Schocken Douglas D., 2010

机译：老年患者不太可能接受基于证据的针对收缩性心力衰竭的药物治疗：对心力衰竭人口（STAMINA-HFP）贫血的研究结果

Women less likely to receive evidence-based heart failure treatment

摘要

著录项

相似文献

相关主题

期刊订阅